BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11330582)

  • 1. Prognostic value of K-ras mutations and allelic imbalance on chromosome 18q in patients with resected colorectal cancer.
    Font A; Abad A; Monzó M; Sanchez JJ; Guillot M; Manzano JL; Piñol M; Ojanguren I; Rosell R
    Dis Colon Rectum; 2001 Apr; 44(4):549-57. PubMed ID: 11330582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
    Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C
    Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer.
    Martínez-López E; Abad A; Font A; Monzó M; Ojanguren I; Pifarré A; Sánchez JJ; Martín C; Rosell R
    Gastroenterology; 1998 Jun; 114(6):1180-7. PubMed ID: 9609754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic loss of chromosome 18q and prognosis in colorectal cancer.
    Jen J; Kim H; Piantadosi S; Liu ZF; Levitt RC; Sistonen P; Kinzler KW; Vogelstein B; Hamilton SR
    N Engl J Med; 1994 Jul; 331(4):213-21. PubMed ID: 8015568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation analysis between loss of heterozygosity at chromosome 18q and prognosis in the stage-II colon cancer patients.
    Wang W; Li YF; Sun XW; Chen G; Zhan YQ; Huang CY; Wan DS; Pan ZZ; Zhou ZW
    Chin J Cancer; 2010 Aug; 29(8):761-7. PubMed ID: 20663324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers.
    Ogino S; Nosho K; Irahara N; Shima K; Baba Y; Kirkner GJ; Meyerhardt JA; Fuchs CS
    J Clin Oncol; 2009 Sep; 27(27):4591-8. PubMed ID: 19704056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator.
    Ogunbiyi OA; Goodfellow PJ; Herfarth K; Gagliardi G; Swanson PE; Birnbaum EH; Read TE; Fleshman JW; Kodner IJ; Moley JF
    J Clin Oncol; 1998 Feb; 16(2):427-33. PubMed ID: 9469325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel multiplexing, polymerase chain reaction-based assay for the analysis of chromosome 18q status in colorectal cancer.
    Erill N; Colomer A; Calvo M; Vidal A; Román R; Verdú M; Cordón-Cardó C; Puig X
    J Mol Diagn; 2005 Oct; 7(4):478-85. PubMed ID: 16237217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity and K-ras gene mutations in gastric cancer.
    Ranzani GN; Renault B; Pellegata NS; Fattorini P; Magni E; Bacci F; Amadori D
    Hum Genet; 1993 Oct; 92(3):244-9. PubMed ID: 8406432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers.
    Halling KC; French AJ; McDonnell SK; Burgart LJ; Schaid DJ; Peterson BJ; Moon-Tasson L; Mahoney MR; Sargent DJ; O'Connell MJ; Witzig TE; Farr GH; Goldberg RM; Thibodeau SN
    J Natl Cancer Inst; 1999 Aug; 91(15):1295-303. PubMed ID: 10433618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of K-ras, BRCA1/2, CHEK2 mutations and microsatellite markers (loss of heterozygosity at 9p, 17p and 18q) in sporadic pancreas adenocarcinomas].
    Amosenko FA; Kazubskaia TP; Gromyko OE; Matveeva TI; Korchagina EL; Nasedkina TV; Gar'kavtseva RF; Kalinin VN
    Mol Biol (Mosk); 2009; 43(3):414-21. PubMed ID: 19548527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular predictors of survival after adjuvant chemotherapy for colon cancer.
    Watanabe T; Wu TT; Catalano PJ; Ueki T; Satriano R; Haller DG; Benson AB; Hamilton SR
    N Engl J Med; 2001 Apr; 344(16):1196-206. PubMed ID: 11309634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of genetic variants in preneoplastic areas of colorectal tumours.
    Lindforss U; Papadogiannakis N; Zetterquist H; Lindberg G; Olivecrona H
    Eur J Surg Oncol; 2003 Aug; 29(6):491-6. PubMed ID: 12875854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic loss is heterogeneous throughout the tumor in colorectal carcinoma.
    Lindforss U; Fredholm H; Papadogiannakis N; Gad A; Zetterquist H; Olivecrona H
    Cancer; 2000 Jun; 88(12):2661-7. PubMed ID: 10870047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients.
    Diep CB; Thorstensen L; Meling GI; Skovlund E; Rognum TO; Lothe RA
    J Clin Oncol; 2003 Mar; 21(5):820-9. PubMed ID: 12610180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of 18q LOH in sporadic colorectal carcinoma.
    Pilozzi E; Ferri M; Onelli MR; Mercantini P; Corigliano N; Duranti E; Dionisi L; Felicioni F; Virgilio E; Ziparo V; Ruco L
    Am Surg; 2011 Jan; 77(1):38-43. PubMed ID: 21396303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMAD4 as a prognostic marker in colorectal cancer.
    Alazzouzi H; Alhopuro P; Salovaara R; Sammalkorpi H; Järvinen H; Mecklin JP; Hemminki A; Schwartz S; Aaltonen LA; Arango D
    Clin Cancer Res; 2005 Apr; 11(7):2606-11. PubMed ID: 15814640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic values of chromosome 18q microsatellite alterations in stage II colonic carcinoma.
    Wang W; Wang GQ; Sun XW; Chen G; Li YF; Zhang LY; Qiu HB; Huang CY; Zhan YQ; Zhou ZW
    World J Gastroenterol; 2010 Dec; 16(47):6026-34. PubMed ID: 21157981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of allelic lost at chromosome 18q21 for stage II colorectal cancer.
    Carethers JM; Hawn MT; Greenson JK; Hitchcock CL; Boland CR
    Gastroenterology; 1998 Jun; 114(6):1188-95. PubMed ID: 9609755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic imbalance and microsatellite instability of the DCC gene in colorectal cancer in patients under the age of 35 using fluorescent DNA technology.
    Chetty R; Naidoo R; Schneider J
    Mol Pathol; 1998 Feb; 51(1):35-8. PubMed ID: 9624418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.